Delayed ghrelin suppression following oral glucose tolerance test in children and adolescents with hypothalamic injury secondary to craniopharyngioma compared with obese controls.
Ghrelin, released from the stomach, acts at the hypothalamus and is associated with initiation of food intake. We hypothesised that patients with craniopharyngioma and hypothalamic obesity (CRHO) would have ghrelin abnormalities. Fifteen CRHO patients and 15 BMI-matched controls underwent oral glucose tolerance test with dynamic ghrelin measurement. From 0-30 minutes, ghrelin (pg/ml) decreased less (43.4 ? 38.8 vs. 70.8 ? 35.8, p < 0.05) and insulin (pmol/l) increased more (1 669.2 ? 861.7 vs. 1 049.1 ? 560.4, p = 0.04) in CRHO compared with controls, respectively. Insulin area-under-the-curve was a weak negative predictor of the 0?30 minutes ghrelin decrease (r(2) = 0.29, p = 0.02). Delayed ghrelin suppression may contribute to obesity in CRHO.
Department of Paediatrics, Graduate Entry Medical School, University of Limerick, Ireland. clodagh.ogorman@ul.ie
Clodagh S
CS
O'Gorman
Judith
J
Simoneau-Roy
Paul
P
Pencharz Mb
Khosrow
K
Adeli
Jill
J
Hamilton
D000293:Adolescent; D000367:Age Factors; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D016022:Case-Control Studies; D002648:Child; D003397:Craniopharyngioma / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D005260:Female; D054439:Ghrelin / Q000097:blood*; D005951:Glucose Tolerance Test; D006801:Humans; D007031:Hypothalamus / Q000378:metabolism* / Q000503:physiopathology; D007328:Insulin / Q000097:blood; D016014:Linear Models; D008297:Male; D009765:Obesity / Q000097:blood / Q000209:etiology* / Q000503:physiopathology; D010911:Pituitary Neoplasms / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors
D015415:Biomarkers; D001786:Blood Glucose; C515349:GHRL protein, human; D054439:Ghrelin; D007328:Insulin